Cargando…

The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome

Limited evidence exists to guide the management of recurrent thrombosis occurring despite therapeutic anticoagulation in patients with thrombotic antiphospholipid syndrome (APS). In this case series, fondaparinux, with or without an antiplatelet agent, provided an effective and safe option in three...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayar, Zara, Burke, Shoshana, Mittal, Prabal, Cohen, Hannah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580031/ https://www.ncbi.nlm.nih.gov/pubmed/36074077 http://dx.doi.org/10.1177/09612033221122147

Ejemplares similares

Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management
por: Sayar, Zara, et al.
Publicado: (2021)

Recurrent Nonbacterial Thrombotic Endocarditis and Primary Antiphospholipid Antibody Syndrome
por: Mandal, Amit K, et al.
Publicado: (2023)

The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
por: Youkhana, Kimberley, et al.
Publicado: (2023)

Clinical Management of Thrombotic Antiphospholipid Syndrome
por: Tumian, Nor Rafeah, et al.
Publicado: (2022)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
por: Anunciación-Llunell, Ariadna, et al.
Publicado: (2022)

Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients
por: Kansuttiviwat, Chalermkiat, et al.
Publicado: (2023)

AZD-1222/fondaparinux sodium: Thrombotic thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
por: Erkan, Doruk, et al.
Publicado: (2016)

The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018)

Management of acute coronary syndromes with fondaparinux
por: Wienbergen, Harm, et al.
Publicado: (2007)

Catastrophic antiphospholipid antibody syndrome in a child with thrombotic microangiopathy
por: Prasad, N., et al.
Publicado: (2012)

Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome
por: Sirinvaravong, Natee, et al.
Publicado: (2018)

Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association
por: Dolin, Hallie Hanna, et al.
Publicado: (2019)

Antiphospholipid Antibody Syndrome: Diffuse Alveolar Hemorrhage and Libman-Sacks Endocarditis in the Absence of Prior Thrombotic Events
por: Hambly, Nathan, et al.
Publicado: (2014)

Antiphospholipid syndrome and valvular heart disease, a complex scenario of thrombotic events, a case report
por: Endara, Santiago A., et al.
Publicado: (2020)

Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward
por: Le Joncour, Alexandre, et al.
Publicado: (2021)

25. Use of rituximab in refractory primary antiphospholipid syndrome with pulmonary and cerebral manifestations
por: Khan, Asim, et al.
Publicado: (2019)

Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)

Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients
por: Fragkou, Paraskevi C., et al.
Publicado: (2022)

Recurrent Thrombotic Events after Catastrophic Antiphopholipid Syndrome
por: Park, Hayne Cho, et al.
Publicado: (2012)

Catastrophic Antiphospholipid Syndrome with Severe Acute Thrombotic Microangiopathy and Hemorrhagic Complications
por: Vieregge, Gerardo B., et al.
Publicado: (2013)

Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome
por: Huang, Yongfa, et al.
Publicado: (2022)

Evaluation of a gene signature related to thrombotic manifestations in antiphospholipid syndrome
por: Jacintho, Bruna Cardoso, et al.
Publicado: (2023)

Antiphospholipid Syndrome Nephropathy with Acute Thrombotic Microangiopathy after Renal Transplantation
por: Suenaga, Atsuhiko, et al.
Publicado: (2023)

Successful Treatment of Catastrophic Antiphospholipid Syndrome Using Rituximab: Case Report and Review of the Literature
por: Stanescu, Cristina, et al.
Publicado: (2021)

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
por: Tektonidou, Maria G, et al.
Publicado: (2019)

Thrombotic storm and cardiovascular manifestations of probable catastrophic antiphospholipid syndrome: the usefulness of multimodal imaging
por: Monteagudo, Paula, et al.
Publicado: (2023)

16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends
por: Cohen, Hannah, et al.
Publicado: (2020)

Diagnosis of antiphospholipid syndrome in routine clinical practice
por: Gardiner, C, et al.
Publicado: (2013)

Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study
por: Su, Zhenzhen, et al.
Publicado: (2022)

Recurrent embolic strokes due to antiphospholipid syndrome and non-bacterial thrombotic endocarditis in a patient with basal cell carcinoma
por: Svantner, Julianna, et al.
Publicado: (2023)

Fondaparinux: A cornerstone drug in acute coronary syndromes
por: Khan, Mohammed Yunus, et al.
Publicado: (2022)

Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2015)

Nonbacterial Thrombotic Endocarditis of the Tricuspid Valve in a Male Patient with Antiphospholipid Syndrome
por: Yordan-Lopez, Nicole M, et al.
Publicado: (2018)

Antiphospholipid antibody syndrome with thrombotic splenic infarcts associated with acute cytomegalovirus infection
por: Denham, Christopher, et al.
Publicado: (2019)

Severe thrombotic complications secondary to antiphospholipid syndrome and undiagnosed systemic lupus erythematosus
por: Barber, Megan R.W., et al.
Publicado: (2022)

Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients
por: Stanisavljevic, Natasa, et al.
Publicado: (2022)

When Will Fondaparinux Induce Thrombocytopenia?
por: Chen, Li-Yu, et al.
Publicado: (2022)

Design and Synthesis of Neutralizable Fondaparinux
por: Zhang, Liangwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p87c16hoip8g6dhs3h20rm4402